These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors. Liu B; Zhuang H; Servaes S Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):21-8. PubMed ID: 23474632 [TBL] [Abstract][Full Text] [Related]
27. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters]. Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441 [TBL] [Abstract][Full Text] [Related]
28. Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker. Choi Y; Lee ES; Woo SK; Lee KC; Chung HK; Kang JH Mol Pharm; 2024 May; 21(5):2435-2440. PubMed ID: 38626389 [TBL] [Abstract][Full Text] [Related]
29. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma. Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Maurea S; Cuocolo A; Reynolds JC; Neumann RD; Salvatore M Q J Nucl Med; 1996 Dec; 40(4):365-71. PubMed ID: 9050342 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933 [TBL] [Abstract][Full Text] [Related]
32. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors. Zagar I; Han R; Mitrovic S Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742 [TBL] [Abstract][Full Text] [Related]
33. Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation. Velchik MG; Alavi A; Kressel HY; Engelman K J Nucl Med; 1989 Mar; 30(3):328-36. PubMed ID: 2738662 [TBL] [Abstract][Full Text] [Related]
34. Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit. Tristam M; Alaamer AS; Fleming JS; Lewington VJ; Zivanovic MA J Nucl Med; 1996 Jun; 37(6):1058-63. PubMed ID: 8683301 [TBL] [Abstract][Full Text] [Related]
35. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. Pérault C; Schvartz C; Wampach H; Liehn JC; Delisle MJ J Nucl Med; 1997 Aug; 38(8):1234-42. PubMed ID: 9255157 [TBL] [Abstract][Full Text] [Related]